GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (OTCPK:NVSEF) » Definitions » Price-to-Funds-From-Operations

Novartis AG (Novartis AG) Price-to-Funds-From-Operations : (As of Apr. 28, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Novartis AG Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Novartis AG (Novartis AG) Business Description

Industry
Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.